Renaissance Capital logo

Rallybio Priced, Nasdaq: RLYB

Phase 1/2 biotech developing antibody therapies for rare diseases.

Industry: Health Care

Latest Trade: $16.73 -1.79 (-9.7%)

First Day Return: +8.5%

Return from IPO: +42.5%

Industry: Health Care

We are a clinical-stage biotechnology company built around a team of seasoned industry experts with a shared purpose and a track record of success in discovering, developing, manufacturing and delivering therapies that meaningfully improve the lives of patients suffering from severe and rare diseases. Our mission at Rallybio is aligned with our expertise, and we believe we have assembled the best people, partners and science to forge new paths to life-changing therapies. Since our launch in January 2018, we have acquired a portfolio of promising product candidates that consists of five programs, and we are focused on further expanding our portfolio with the goal of making a profound impact on the lives of even more patients. We are drawing on our decades of knowledge and experience with a determination to tackle the undone, the too difficult, the inaccessible – and change the odds for rare disease patients. Our most advanced program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, or FNAIT, a potentially life-threatening rare hematological disease that impacts fetuses and newborns. We are evaluating RLYB211, a polyclonal anti-HPA-1a antibody, in a Phase 1/2 clinical trial, which we believe has established proof of concept for RLYB211 and provides support for our proposed mechanism of action. We plan to move our FNAIT program forward with our lead product candidate, RLYB212, a monoclonal anti-HPA-1a antibody.
more less
IPO News for Rallybio
more
IPO Data
IPO File Date 07/02/2021
Offer Price $13.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.2
Deal Size ($mm) $81
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/28/2021
Offer Price $13.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.2
Deal Size ($mm) $81
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters New Haven, CT
Founded 2018
Employees 22
Website rallybio.com